NEWARK, Del, April 10, 2023 (GLOBE NEWSWIRE) -- According to FMI estimations, the Autoimmune Disease Testing Market could increase from US$ 6.07 billion in 2023 to US$ 15.75 billion by 2033. The ...

Increase in prevalence of autoimmune diseases, rise in technological advancements, and rise in awareness about early diagnosis are the major factors which drive the global market growth. Increasing ...

DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Autoimmune IVD Testing Market" report to their offering. This report provides important business planning information ...

CARLSBAD, Calif., Jan. 11, 2026 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing, today announced select preliminary unaudited financial results for the fourth ...

The global market for Autoimmune Disease Testing is expected to grow from US$ 6.07 billion in 2023 to $15.75 billion by 2033. According to FMI, global demand for autoimmune disease testing could grow ...

The global market for Autoimmune Disease Testing is expected to grow from US$ 6.07 billion in 2023 to $15.75 billion by 2033. According to FMI, global demand for autoimmune disease testing could grow ...

The global autoimmune disease testing market is set to grow from USD 6 Bn in 2025 to USD 12.6 Bn by 2031, registering a CAGR of 9.2% during the forecast period LOS ANGELES, CA, UNITED STATES, March 10 ...

According to the report, the autoimmune disease testing market was valued at $5.3 billion in 2023, and is estimated to reach $12.1 billion by 2033, growing at a CAGR of 8.6% from 2024 to 2033.